A clinical research consortium sponsored by NIAID and JDRF
A research trial of Aralast in new-onset type 1 diabetes
Additional Type 1 Diabetes Studies.
RETAIN is no longer enrolling participants.
For information about the EXTEND study, another type 1 diabetes clinical trial being conducted by the Immune Tolerance Network, please visit extendstudy.org.
